The tumor volume in the AAV-PCBP1-AS1 group began to decline on the 22nd day, and subsequent immunohistochemistry also confirmed that after knocking down PCBP1-AS1, tumor AR, AR-V7, and Ki-67 expressions were significantly reduced (Fig. 5K). The gene discussed is AR; the disease is neoplasm.